[ARWR] YoY Quarter Result on 31-Mar-2013 [#Q2]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
09-May-2013
Financial Year
2013
Quarter
31-Mar-2013 [#Q2]
Profit Trend
QoQ- -46.47%
YoY- -26.67%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Quarter Result
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Revenue 44 44 44 44 31 296 157 -19.08%
PBT -20,816 -28,684 -13,983 -6,940 -5,584 -1,087 -2,128 46.19%
Tax -449 -413 2,797 -70 402 -1,087,336 -326 5.47%
NP -20,816 -28,684 -13,943 -6,758 -5,335 2,905 -1,854 49.58%
Tax Rate - - - - - - - -
Total Cost 20,860 28,728 13,986 6,802 5,366 -2,609 2,011 47.62%
Ratio Analysis
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
NP Margin -47,579.11 -65,563.41 -31,868.62 -15,446.71 -17,072.75 981.04 -1,178.27 85.11%
Per Share
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
EPS -0.35 -0.51 -0.31 -0.41 -0.50 0.40 -0.29 3.18%
EPS Diluted -0.35 -0.51 -0.31 -0.41 -0.50 0.37 -0.29 3.18%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.